16-30 of 334
Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Project Oncology®Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Jason Starr, DO
Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeFamilial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
Steve Jackson, PharmD
Nivedita Patni, MD
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease
Brian P. McDonough, MD, FAAFP
Doreen Addrizzo-Harris, MD
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Clinician's RoundtableEmerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Alexandria May, PharmD, BCPS
David E. Griffith, MD
Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Project Oncology®Overcoming Clinical Inertia to Individualize Myelofibrosis Treatment
Alexandria May, PharmD, BCPS
Prithviraj Bose, MD
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
- advertisement
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Evaluating Port-Wine Capillary Malformations in Children
On the Frontlines of Pediatric Skin HealthEvaluating Port-Wine Capillary Malformations in Children
Kristen Kelly, MD
Alexandria May, PharmD, BCPS
Comprehensive Management of Pediatric Port-Wine Capillary Malformations
On the Frontlines of Pediatric Skin HealthComprehensive Management of Pediatric Port-Wine Capillary Malformations
Kristen Kelly, MD
Alexandria May, PharmD, BCPS
Helping Patients Understand GPP’s Unpredictable and Systemic Nature
DermConsultHelping Patients Understand GPP’s Unpredictable and Systemic Nature
Charles Turck, PharmD, BCPS, BCCCP
Andrew Dorizas, MD, FAAD, ASMS
- advertisement
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Ronald Witteles, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
